Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 8, 2007, Pages 2892-2897

  Boumendjel, Ahcene ^a   Macalou, Sira ^b   Ahmed Belkacem, Abdelhakim ^b   Blanc, Madeleine ^a   Di Pietro, Attilio ^b  

^a Laboratoire de Pharmacochimie   (France)

^b University Lyon i   (France)

Author keywords

ABCG2; Acridones; BCRP; MDR

Indexed keywords

1 HYDROXY 10H ACRIDIN 9 ONE; 1 HYDROXY 3 METHOXY 10H ACRIDIN 9 ONE; 1 HYDROXY 3 TRIFLUOROMETHYL 10H ACRIDIN 9 ONE; 1 METHOXY 10H ACRIDIN 9 ONE; 1 METHOXY 3 TRIFLUOROMETHYL 10H ACRIDIN 9 ONE; 1,2 DIMETHOXY 10H ACRIDIN 9 ONE; 1,3 DIMETHOXY 10H ACRIDIN 9 ONE; 2 HYDROXY 10H ACRIDIN 9 ONE; 2 METHOXY 10H ACRIDIN 9 ONE; 6 METHOXY 9 OXO 9,10 DIHYDROACRIDINE CARBOXYLIC ACID(3,4 DIMETHOXYPHENETHYL)AMIDE; 6 METHOXY 9 OXO 9,10 DIHYDROACRIDINE CARBOXYLIC ACID(4 METHOXYPHENETHYL)AMIDE; 9 OXO 9,10 DIHYDROACRIDINE 4 CARBOXYLIC ACID 3,4 DIMETHOXYPHENETHYLAMIDE; 9 OXO 9,10 DIHYDROACRIDINE 4 CARBOXYLIC ACID 4 METHOXYPHENETHYLAMIDE; ACRIDONE DERIVATIVE; BREAST CANCER RESISTANCE PROTEIN; CHROMONE DERIVATIVE; ELACRIDAR; FLAVONE DERIVATIVE; MITOXANTRONE; PROTEIN INHIBITOR; TECTOCHRYSIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG DESIGN; DRUG INHIBITION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; DRUG TRANSPORT; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; STRUCTURE ACTIVITY RELATION; WILD TYPE;

EID: 33947149142     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.02.017     Document Type: Article

References (30)

1. In: Holland B., Cole S.P.C., Kuchler K., and Higgins C.F. (Eds). ABC Proteins from Bacteria to Man (2003), Academic Press, San Diego
2. Endicott J.A., and Ling V. Annu. Rev. Biochem. 58 (1989) 137
3. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Science 25 8 (1992) 1650
4. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Roshi A.K., and Ross D.D. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15665
5. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., and Dean M. Cancer Res. 58 (1998) 5337
6. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., and Bates S.E. Cancer Res. 59 (1999) 8
7. Litman T., Druley T.E., Stein W.D., and Bates S.E. Cell. Mol. Life. Sci. 58 (2001) 931
8. Maliepaard M., van Gastelen M.A., Jong L.A., Pluim D., van Waardenburg R.C., Ruevekamp-Helmers M.C., Floot B.G., and Schellens J.H. Cancer Res. 61 (1999) 3458
9. Robey R.W., Medina-Perez W.Y., Nishiyama K., Lahusen T., Miyake K., Litman T., Senderowicz A.M., Ross D.D., and Bates S.E. Clin. Cancer Res. 7 (2001) 145
10. Su Y., Lee S.-H., and Sinko P.J. Eur. J. Pharm. Sci. 29 (2006) 102
11. Wang X., Furukawa T., Nitanda T., Okamoto M., Sugimoto Y., Akiyama S., and Baba M. Mol. Pharmacol. 63 (2003) 65
12. Schinkel A.H., and Jonker J.W. Adv. Drug Delivery Rev. 55 (2003) 3
13. Ahmed-Belkacem A., Pozza A., Macalou S.F., Perez-Victoria J.M., Boumendjel A., and Di Pietro A. Anti-Cancer Drugs 17 (2006) 239
14. Leggas M., Panetta J.C., Zhuang Y., Schuetz J.D., Johnston B., Bai F., Sorrentino B., Zhou S., Houghton P.J., and Stewart C.F. Cancer Res. (2006)
15. Jekerle V., Klinkhammer W., Scollard D.A., Breitbach K., Reilly R.M., Piquette-Miller M., and Wiese M. Int. J. Cancer 119 (2006) 414
16. Wallstab A., Koester M., Bohme M., and Keppler D. Br. J. Cancer 79 (1999) 1053
17. Traunecker H.C.L., Stevens M.C.G., Kerr D.J., and Ferry D.R. Br. J. Cancer 81 (1999) 942
18. Evers R., Kool M., Smith A.J., van Deemter L., de Haas M., and Borst P. Br. J. Cancer 83 (2000) 366
19. Krishnegowda G., Thimmaiah P., Hegde R., Dass C., Houghton P.J., and Thimmaiah K.N. Bioorg. Med. Chem. 10 (2002) 2367
20. Rabindran S.K., He H., Singh M., Brown E., Collins K.I., Annable T., and Greenberger L.M. Cancer Res. 58 (1998) 5850
21. Rabindran S.K., Ross D.D., Doyle L.A., Yang W., and Greenberger L.M. Cancer Res. 60 (2000) 47
22. van Loevezijn A., Allen J.D., Schinkel A.H., and Koomen G.-J. Bioorg. Med. Chem. Lett. 11 (2001) 29
23. Ahmed-Belkacem A., Pozza A., Munoz-Martinez F., Bates S.E., Castanys S., Gamarro F., Di Pietro A., and Perez-Victoria J.M. Cancer Res. 65 (2005) 4852
24. Boumendjel A., Nicolle E., Moraux T., Gerby B., Blanc M., Ronot X., and Boutonnat J. J. Med. Chem. 48 (2005) 7275
25. Michael J.P. Nat. Prod. Rep. 22 (2005) 627
26. Tercio J., Ferreira B., Catani V., and Comasseto J.V. Synthesis 2 (1987) 149
27. Boumendjel A., DiPietro A., Dumontet C., and Barron D. Med. Res. Rev. 22 (2002) 51
28. Boumendjel A., Conseil G., Baubichon-Cortay H., and Di Pietro A. Med. Res. Rev. 25 (2005) 453
29. Allen J.D., van Loevezijn A., Lakai J.M., van der Valk M., van Tellingen O., Reid G., Schellens J.H., Koomen G.J., and Schinkel A.H. Mol. Cancer Ther. 1 (2002) 417
30. Horie T., Tsukayama M., Kawamura Y., and Seno M. J. Org. Chem. 52 (1987) 4202